Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Gut
|
March 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Cancer Research
|
June 8, 2014
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties
Shumei Song, Jaffer A Ajani, Soichiro Honjo, et al.
Cancer Letters
|
November 27, 2024
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer
Katsuhiro Yoshimura, Gengyi Zou, Yibo Fan, et al.
Nature Medicine
|
May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Jianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Cancer Research
|
March 5, 2020
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling
Jian Chen, Abhisek Mitra, Shulin Li, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 24, 2021
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
Shumei Song, Yan Xu, Longfei Huo, et al.
Nature
|
July 24, 2024
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer
Juhyung Park, Jibo Wu, Krzysztof J Szkop, et al.
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Medical Oncology (Northwood, London, England)
|
July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients
Dilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Gut
|
March 31, 2021
Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting <i>ARID1A</i> deficiency
Xiaochuan Dong, Shumei Song, Yuan Li, et al.
Cancer Research
|
June 8, 2014
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties
Shumei Song, Jaffer A Ajani, Soichiro Honjo, et al.
Cancer Letters
|
November 27, 2024
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer
Katsuhiro Yoshimura, Gengyi Zou, Yibo Fan, et al.
Nature Medicine
|
May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Jianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Cancer Research
|
March 5, 2020
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling
Jian Chen, Abhisek Mitra, Shulin Li, et al.
Molecular Cancer
|
March 26, 2021
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 24, 2021
Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma
Shumei Song, Yan Xu, Longfei Huo, et al.
Nature
|
July 24, 2024
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer
Juhyung Park, Jibo Wu, Krzysztof J Szkop, et al.
Molecular Cancer
|
October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Medical Oncology (Northwood, London, England)
|
July 8, 2017
Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients
Dilsa Mizrak Kaya, Xiaochuan Dong, Graciela M Nogueras-González, et al.
Page
of 12